These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38559561)

  • 41. Survival in patients with surgically treated brain metastases: does infratentorial location matter?
    Hamed M; Potthoff AL; Heimann M; Schäfer N; Borger V; Radbruch A; Herrlinger U; Vatter H; Schneider M
    Neurosurg Rev; 2023 Mar; 46(1):80. PubMed ID: 36997703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Navigating Post-Operative Outcomes: A Comprehensive Reframing of an Original Graded Prognostic Assessment in Patients with Brain Metastases.
    Goldberg M; Mondragon-Soto MG; Dieringer L; Altawalbeh G; Pöser P; Baumgart L; Wiestler B; Gempt J; Meyer B; Aftahy AK
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
    Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
    Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of brain metastases from gastrointestinal primaries: Comparing whole-brain radiotherapy and stereotactic radiosurgery in terms of survival.
    Dincer S; Gurbuz D
    North Clin Istanb; 2022; 9(1):47-56. PubMed ID: 35340309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
    Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC
    JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oncologic Outcome and Immune Responses of Radiotherapy with Anti-PD-1 Treatment for Brain Metastases Regarding Timing and Benefiting Subgroups.
    Trommer M; Adams A; Celik E; Fan J; Funken D; Herter JM; Linde P; Morgenthaler J; Wegen S; Mauch C; Franklin C; Galldiks N; Werner JM; Kocher M; Rueß D; Ruge M; Meißner AK; Baues C; Marnitz S
    Cancers (Basel); 2022 Feb; 14(5):. PubMed ID: 35267546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of removed tumor volume and location on patient outcome in glioblastoma.
    Awad AW; Karsy M; Sanai N; Spetzler R; Zhang Y; Xu Y; Mahan MA
    J Neurooncol; 2017 Oct; 135(1):161-171. PubMed ID: 28685405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Factors affecting survival in 37 consecutive patients undergoing de novo stereotactic radiosurgery for contiguous sites of vertebral body metastasis from renal cell carcinoma.
    Sellin JN; Reichardt W; Bishop AJ; Suki D; Rhines LD; Settle SH; Brown PD; Li J; Rao G; Chang EL; Tatsui CE
    J Neurosurg Spine; 2015 Jan; 22(1):52-9. PubMed ID: 25360530
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of five or more brain metastases with stereotactic radiosurgery.
    Hunter GK; Suh JH; Reuther AM; Vogelbaum MA; Barnett GH; Angelov L; Weil RJ; Neyman G; Chao ST
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1394-8. PubMed ID: 22209150
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases.
    Juloori A; Miller JA; Parsai S; Kotecha R; Ahluwalia MS; Mohammadi AM; Murphy ES; Suh JH; Barnett GH; Yu JS; Vogelbaum MA; Rini B; Garcia J; Stevens GH; Angelov L; Chao ST
    J Neurosurg; 2020 Jan; 132(1):188-196. PubMed ID: 30660120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
    Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
    Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing outcomes: neurosurgical resection in brain metastasis patients with poor Karnofsky performance score - a comprehensive survival analysis.
    Goldberg M; Mondragon-Soto MG; Altawalbeh G; Baumgart L; Gempt J; Bernhardt D; Combs SE; Meyer B; Aftahy AK
    Front Oncol; 2023; 13():1343500. PubMed ID: 38269027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
    Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH; Olson JJ; Oyesiku NM; Wait SD; Curran WJ; Shu HK; Prabhu RS
    Neurosurgery; 2016 Aug; 79(2):279-85. PubMed ID: 26528673
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients.
    Pontoriero A; Conti A; Iatì G; Mondello S; Aiello D; Rifatto C; Risoleti E; Mazzei M; Tomasello F; Pergolizzi S; De Renzis C
    Neurosurg Rev; 2016 Jul; 39(3):495-504. PubMed ID: 27106896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.